Align Technology, Inc. (NASDAQ:ALGN) – Research analysts at William Blair increased their FY2019 earnings per share estimates for shares of Align Technology in a note issued to investors on Friday. William Blair analyst J. Kreger now expects that the medical equipment provider will earn $5.11 per share for the year, up from their previous estimate of $4.97. William Blair also issued estimates for Align Technology’s FY2020 earnings at $6.01 EPS.

ALGN has been the subject of several other reports. Morgan Stanley reiterated an “overweight” rating and issued a $175.00 price target on shares of Align Technology in a report on Monday, June 19th. They noted that the move was a valuation call. Leerink Swann upped their price objective on Align Technology from $149.00 to $194.00 and gave the stock an “outperform” rating in a report on Monday, June 26th. Northcoast Research restated a “buy” rating and set a $186.00 price objective (up from $164.00) on shares of Align Technology in a report on Wednesday, June 21st. Robert W. Baird upgraded Align Technology from a “neutral” rating to an “outperform” rating and upped their price objective for the stock from $105.00 to $155.00 in a report on Friday, April 28th. Finally, Piper Jaffray Companies reiterated a “buy” rating and issued a $176.00 price target on shares of Align Technology in a report on Friday, July 28th. One research analyst has rated the stock with a hold rating and nine have issued a buy rating to the stock. Align Technology presently has an average rating of “Buy” and an average price target of $174.40.

WARNING: “FY2019 EPS Estimates for Align Technology, Inc. (ALGN) Lifted by Analyst” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://www.thecerbatgem.com/2017/08/21/fy2019-eps-estimates-for-align-technology-inc-algn-lifted-by-analyst.html.

Shares of Align Technology (ALGN) opened at 168.61 on Monday. Align Technology has a 1-year low of $83.27 and a 1-year high of $179.76. The firm’s 50-day moving average price is $162.73 and its 200 day moving average price is $132.63. The firm has a market cap of $13.51 billion, a PE ratio of 57.74 and a beta of 1.55.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $0.85 EPS for the quarter, beating the consensus estimate of $0.73 by $0.12. The firm had revenue of $356.50 million during the quarter, compared to analysts’ expectations of $343.43 million. Align Technology had a return on equity of 23.87% and a net margin of 19.18%. The business’s revenue for the quarter was up 32.3% on a year-over-year basis. During the same quarter last year, the firm earned $0.62 earnings per share.

In other Align Technology news, Director Joseph Lacob sold 50,000 shares of the business’s stock in a transaction dated Wednesday, May 31st. The shares were sold at an average price of $144.98, for a total value of $7,249,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, VP Sreelakshmi Kolli sold 1,000 shares of the business’s stock in a transaction dated Tuesday, May 30th. The stock was sold at an average price of $144.00, for a total transaction of $144,000.00. Following the completion of the transaction, the vice president now directly owns 23,785 shares of the company’s stock, valued at $3,425,040. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 54,874 shares of company stock worth $7,950,701. Company insiders own 2.00% of the company’s stock.

Several institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in Align Technology by 16.5% in the second quarter. Vanguard Group Inc. now owns 7,299,099 shares of the medical equipment provider’s stock worth $1,095,740,000 after buying an additional 1,034,254 shares during the period. BlackRock Inc. increased its stake in Align Technology by 5,738.0% in the first quarter. BlackRock Inc. now owns 6,640,531 shares of the medical equipment provider’s stock worth $761,737,000 after buying an additional 6,526,784 shares during the period. Polen Capital Management LLC increased its stake in shares of Align Technology by 6.8% in the second quarter. Polen Capital Management LLC now owns 3,362,570 shares of the medical equipment provider’s stock valued at $504,789,000 after buying an additional 212,773 shares during the last quarter. State Street Corp increased its stake in shares of Align Technology by 32.2% in the second quarter. State Street Corp now owns 3,143,095 shares of the medical equipment provider’s stock valued at $471,823,000 after buying an additional 765,189 shares during the last quarter. Finally, Renaissance Technologies LLC increased its stake in shares of Align Technology by 11.3% in the second quarter. Renaissance Technologies LLC now owns 1,587,681 shares of the medical equipment provider’s stock valued at $238,343,000 after buying an additional 160,881 shares during the last quarter. 88.07% of the stock is owned by institutional investors.

Align Technology Company Profile

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

Earnings History and Estimates for Align Technology (NASDAQ:ALGN)

Receive News & Stock Ratings for Align Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology Inc. and related stocks with our FREE daily email newsletter.